We're making updates and relaunching soon. Get notified

Straight answers about GLP-1 medications

Plain-language guides on dosing, side effects, costs, and what to look for in a provider.

Relaunching Soon

  • Relaunching as an independent GLP-1 guide
  • Get notified when we relaunch
  • We only ask for your email
Get Started

One email to confirm. Unsubscribe anytime.

How to Get GLP-1 in Columbia, MD for Weight Loss

The short answer

The good news: if you live in Columbia and want to explore GLP-1 medication for weight loss, you have several ways to get it. You can ask your primary care provider, book with a clinic that focuses on weight management, or use a telehealth program whose providers hold a Maryland license. Whichever route you choose, a licensed provider reviews your health history and decides whether a GLP-1 medication is appropriate. An estimated 32.2% of Columbia adults have obesity, according to CDC PLACES 2023 data, below both the Maryland (32.7%) and national (33.1%) rates. As of October 2026, Maryland Medicaid does not cover GLP-1 medications prescribed for weight loss. Read on for how each option works, the Medicaid facts, and what to check before you pick a provider.

Obesity and metabolic health in Columbia

Adults with obesity (2023 estimate)

32.2%

Adults with diagnosed diabetes

10.6%

No leisure-time physical activity

16.9%

The CDC estimates that 32.2% of Columbia adults have obesity (95% confidence interval 28.2% to 36.3%), out of an adult population of about 81,430. That is lower than the statewide Maryland rate of 32.7% (2024) and lower than the national rate of 33.1% (2024).

MeasureColumbiaMarylandNational
Adult obesity32.2%32.7%33.1%
No leisure-time physical activity16.9%19.5%22.5%

City figures: CDC PLACES: Local Data for Better Health, Place Data, 2025 release, 2023 estimates. State and national figures: CDC BRFSS. Full sources and methodology are listed at the bottom of this page.

The full health picture in Columbia

Obesity rarely travels alone. The same CDC dataset estimates several related measures for Columbia adults, each of which is part of what a provider weighs when deciding whether a GLP-1 medication is appropriate:

MeasureEstimate95% confidence interval
Adults with diagnosed diabetes10.6%9.4% to 11.9%
Adults with high blood pressure35.0%32.3% to 37.8%
Adults with depression18.8%16.5% to 21.2%
Adults sleeping less than 7 hours a night38.0%33.9% to 42.2%
Adults 18-64 without health insurance6.3%5.5% to 7.2%
Routine checkup in the past year80.6%78.0% to 83.0%
Fair or poor self-rated health13.3%11.8% to 14.9%

What direct surveys show for the Baltimore-Columbia-Towson metro area

The city figures above are model-based estimates. As a cross-check, the CDC also surveys the Baltimore-Columbia-Towson metropolitan area directly through its SMART BRFSS program: in 2023, 33.8% of surveyed metro-area adults had obesity (95% confidence interval 31.8% to 35.8%, from 1,619 respondents). The metro area includes suburbs and neighboring communities, so it will not match the city estimate exactly, but the two figures tell a consistent story about the region.

Columbia vs other Maryland cities

City-level obesity estimates vary meaningfully across Maryland. Compare Columbia with nearby-ranked Maryland cities:

Or compare every Maryland city we track, plus Medicaid coverage rules and how Maryland compares with other states, on the statewide Maryland page.

Does Maryland Medicaid cover GLP-1 medications for weight loss?

Medicaid rules are set at the state level, so what matters for Columbia residents is the Maryland program. As of October 2026, Maryland Medicaid does not cover GLP-1 medications prescribed for weight loss. Maryland Medicaid does not cover weight-management semaglutide when the sole indication is chronic weight management; semaglutide is covered only for cardiovascular disease or MASH and tirzepatide only for obstructive sleep apnea, with prior authorization. A 2026 bill passed by the General Assembly (SB 496) authorizes, but does not require, broader obesity medication coverage beginning January 1, 2027. Coverage rules change frequently, vary by plan, and almost always require prior authorization when weight-management GLP-1s are covered at all. Confirm your current benefits directly with Maryland Medicaid or your plan administrator before making any decisions.

Nationally, obesity-drug coverage in Medicaid remains limited. As of October 2026, our review of the 51 Medicaid programs (50 states and DC) found 8 that cover at least one GLP-1 medication for weight management, usually with prior authorization, 3 that cover them only under narrow conditions, and 8 that ended that coverage in 2025 or 2026. Coverage for type 2 diabetes is more common and is separate from weight-management coverage.

GLP-1 telehealth in Columbia: no clinic visit required

If you do not have coverage, do not meet your plan’s criteria, or would rather not go through prior authorization, you will most likely pay cash. In Columbia that usually means one of two routes:

  • In-person care. A primary care provider, an obesity medicine specialist, or a weight management clinic in Columbia. You get face-to-face visits and local lab work, and the prescription is filled at a retail or compounding pharmacy.
  • Telehealth. An online program whose providers are licensed in Maryland. Visits happen by questionnaire, messaging, or video, and medication is usually shipped to your address.

With telehealth there is no office to drive to and no need to fit appointments around work. In-person care can make it easier to manage other health conditions alongside a GLP-1 medication. Either way, you do not need a diabetes diagnosis to be evaluated for weight management, and a licensed provider decides whether a prescription is appropriate. Before you choose, check each option on the same points:

  • Licensing in Maryland. The prescriber must hold a license that covers Maryland. You can confirm a license on the Maryland licensing board’s website.
  • The pharmacy. Which pharmacy fills the prescription, whether it is a retail or compounding pharmacy, and whether it is licensed to ship to Maryland.
  • The medication and form. Brand-name or compounded, semaglutide or tirzepatide, injection or tablet.
  • Total cost, including dose increases. Many programs charge more as the dose goes up, so ask what you would pay at each dose, not only in the first month.
  • What the price includes. Provider visits and follow-ups, lab work, shipping, and any program fee. Some programs bundle these; others bill them separately.
  • How the first visit works. An online questionnaire, messaging, or a live video visit. State telehealth rules and each program’s own policy both affect this.
  • Cancellation and refund terms. How to pause or stop, and whether you are charged if a provider decides a prescription is not appropriate.

For more on reading GLP-1 prices, see what GLP-1 treatment costs, or start with the GLP-1 weight loss guide.

Compounded semaglutide and tirzepatide in Columbia

Some telehealth programs and clinics that serve Columbia residents prescribe compounded semaglutide or compounded tirzepatide, usually at a lower advertised price than brand-name products. Compounded medications are prepared by state-licensed compounding pharmacies and require a prescription from a licensed provider. If a program offers one, ask which pharmacy prepares it and confirm that the pharmacy is licensed to dispense in Maryland.

Compounded medications are not FDA-approved and may differ from brand-name products in formulation, purity, and potency, so a provider should review whether one is appropriate for you before anything is prescribed. These guides cover the specifics:

Who qualifies for GLP-1 weight management in Columbia

You do not need a diabetes diagnosis to be considered for GLP-1 weight management. A licensed provider generally evaluates candidates with a body mass index (BMI) of 30 or higher, or 27 or higher when paired with a weight-related health condition such as high blood pressure, elevated cholesterol, or prediabetes. The provider reviews your full health history, current medications, and goals before deciding whether treatment is appropriate, so the decision is always individual and never automatic.

On age, each program sets its own limits, and most telehealth weight-management programs serve adults 18 and older. Maryland rules on consent to medical care can also affect the minimum age, so confirm the requirement with any program you are considering. A licensed provider makes the final prescribing decision.

A large share of people seeking GLP-1 weight management in Columbia are women between roughly 35 and 50 who are navigating weight changes tied to perimenopause, when shifting hormones can make weight harder to manage even when nothing else has changed. If that describes you, the appetite and metabolic effects of GLP-1 medications are one option worth discussing with a provider. You can read more about whether GLP-1 medications are appropriate if you are not diabetic and how GLP-1 medications work.

How to get GLP-1 in Columbia

For someone in Columbia, the steps usually look like this:

  1. Check your coverage. If you have Maryland Medicaid or private insurance, find out whether it covers GLP-1 medications for weight management and what prior authorization requires.
  2. Choose a route: an in-person provider in Columbia, or a telehealth program whose providers are licensed in Maryland.
  3. Compare two or three options on licensing, pharmacy, total cost, and what the price includes, using the checklist above.
  4. At the program or practice you choose, a licensed provider reviews your health history, current medications, and goals and decides whether a GLP-1 medication is appropriate. Not everyone receives a prescription.
  5. If a prescription is written, a pharmacy fills it. Telehealth programs usually ship the medication to your address.

For coverage rules and how Maryland compares with other states, see the statewide Maryland data.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

Data sources and methodology

  • City health estimates: CDC PLACES: Local Data for Better Health, Place Data, 2025 release, 2023 estimates for Columbia, Maryland (Census place 2419125). PLACES figures are model-based small-area estimates: the CDC combines BRFSS survey responses with Census population data to produce city-level figures. They are the CDC’s official local estimates, but they are estimates rather than direct city surveys, which is why each figure is shown with its 95% confidence interval.
  • Metro-area survey data: CDC Behavioral Risk Factor Surveillance System, SMART MMSA Prevalence Data, 2023 crude prevalence for the Baltimore-Columbia-Towson metropolitan area, from direct BRFSS interviews (1,619 respondents).
  • State and national benchmarks: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System. Maryland adult obesity 32.7% (2024); national 33.1% (2024). Based on self-reported height and weight.
  • Medicaid coverage: Transformation Health review of each state’s Medicaid preferred drug list, prior-authorization criteria, and provider notices, as of October 2026. Maryland-specific status verified against the Maryland Medicaid preferred drug list and prior-authorization criteria, the state’s primary source. State Medicaid coverage of GLP-1 medications for weight loss changes frequently and is summarized here for general information only. Always confirm current benefits directly with Maryland Medicaid or your plan.
  • Data current as of: 2023 CDC PLACES release. Page last updated: October 17, 2026.

Important: Compounded medications are not FDA-approved products. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. City health figures are CDC model-based estimates. Medicaid coverage information is general, changes frequently, and should be confirmed with your state program. A licensed provider decides whether a prescription is appropriate. Results vary by individual. Transformation Health is an independent guide. It does not provide medical care, prescribe, or sell medication.

FAQ

Frequently Asked Questions

Everything you need to know about getting started.

Still have questions?

Contact our support team
What percentage of adults in Columbia have obesity?
An estimated 32.2% of adults in Columbia have obesity, according to CDC PLACES 2023 data (95% confidence interval 28.2% to 36.3%). That is lower than the Maryland rate of 32.7% and lower than the national rate of 33.1%.
Can I get a GLP-1 prescription online in Columbia?
Yes, if you use a telehealth program whose providers are licensed in Maryland. GLP-1 medications always require a prescription. A licensed provider at the program you choose reviews your health history and decides whether a GLP-1 medication is appropriate, and not everyone receives a prescription. Some programs use an online questionnaire and others require a live video visit, so ask how the first visit works.
Do I need to visit a weight loss clinic in Columbia to get GLP-1?
No. A clinic visit is one option, not a requirement. Telehealth programs whose providers are licensed in Maryland can review your health history online and, if a provider decides a GLP-1 medication is appropriate, send the prescription to a pharmacy that ships to Columbia. Some people prefer an in-person clinic or their primary care provider for face-to-face visits and local lab work.
Does Maryland Medicaid cover GLP-1 medications for weight loss?
As of October 2026, Maryland Medicaid does not cover GLP-1 medications prescribed for weight loss. Confirm current benefits directly with your state Medicaid program, as coverage and prior-authorization rules change frequently.
Can I get compounded semaglutide or tirzepatide in Columbia?
Some telehealth programs and clinics that serve Columbia residents prescribe compounded semaglutide or compounded tirzepatide. A prescription from a licensed provider is required. Compounded medications are not FDA-approved and may differ from brand-name products in formulation, purity, and potency. If a program offers one, ask which pharmacy prepares it and confirm that the pharmacy is licensed to dispense in Maryland.
How much does a GLP-1 weight loss program cost without insurance?
Cash prices vary by medication (semaglutide or tirzepatide), by form, by dose, and by whether the product is brand-name or compounded. Some telehealth programs bundle medication, provider visits, lab work, and shipping into one monthly price, while others bill them separately, and many charge more as the dose increases. Compare the total cost at the doses you expect to reach, not just the starting price.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

About This Site: Disclosures

Who We Are

transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. Providers and programs mentioned on this site are independent third parties.

How We Make Money

Transformation Health does not accept payment from providers.

Educational Purpose

This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Results vary. Trial results describe study participants and are not a prediction for any individual.

Compounded Medications

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy, Ozempic, Zepbound, or Mounjaro. They may differ in formulation, purity, and potency.

Trademarks

Wegovy and Ozempic are trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies.